320 related articles for article (PubMed ID: 28875861)
1. Therapeutic Monoclonal Antibodies and Multiple Sclerosis: The Essentials.
Heliopoulos I; Patousi A
Med Chem; 2018 Feb; 14(2):144-154. PubMed ID: 28875861
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody treatments for multiple sclerosis.
Rose JW; Foley J; Carlson N
Curr Neurol Neurosci Rep; 2008 Sep; 8(5):419-26. PubMed ID: 18713579
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies in treatment of multiple sclerosis.
Rommer PS; Dudesek A; Stüve O; Zettl UK
Clin Exp Immunol; 2014 Mar; 175(3):373-84. PubMed ID: 24001305
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of antibody therapy in demyelinating diseases.
Akaishi T; Nakashima I
Int Immunol; 2017 Jul; 29(7):327-335. PubMed ID: 28910968
[TBL] [Abstract][Full Text] [Related]
5. Established and novel disease-modifying treatments in multiple sclerosis.
Cross AH; Naismith RT
J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management.
Krajnc N; Bsteh G; Berger T; Mares J; Hartung HP
Neurotherapeutics; 2022 Apr; 19(3):753-773. PubMed ID: 35378683
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal antibodies for the treatment of multiple sclerosis].
Sánchez-Seco VG; Casanova Peño I; Arroyo González R
Med Clin (Barc); 2014 Dec; 143 Suppl 3():30-4. PubMed ID: 25732947
[TBL] [Abstract][Full Text] [Related]
8. Safety of monoclonal antibodies for the treatment of multiple sclerosis.
McGinley MP; Moss BP; Cohen JA
Expert Opin Drug Saf; 2017 Jan; 16(1):89-100. PubMed ID: 27756172
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.
Gensicke H; Leppert D; Yaldizli Ö; Lindberg RL; Mehling M; Kappos L; Kuhle J
CNS Drugs; 2012 Jan; 26(1):11-37. PubMed ID: 22171583
[TBL] [Abstract][Full Text] [Related]
10. Treating multiple sclerosis with monoclonal antibodies.
Buttmann M; Rieckmann P
Expert Rev Neurother; 2008 Mar; 8(3):433-55. PubMed ID: 18345973
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies in MS: mechanisms of action.
Bielekova B; Becker BL
Neurology; 2010 Jan; 74 Suppl 1():S31-40. PubMed ID: 20038761
[TBL] [Abstract][Full Text] [Related]
12. Drug insight: using monoclonal antibodies to treat multiple sclerosis.
Hohlfeld R; Wekerle H
Nat Clin Pract Neurol; 2005 Nov; 1(1):34-44. PubMed ID: 16932490
[TBL] [Abstract][Full Text] [Related]
13. Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
Singer BA
Semin Neurol; 2016 Apr; 36(2):140-7. PubMed ID: 27116720
[TBL] [Abstract][Full Text] [Related]
14. CD20 monoclonal antibodies for the treatment of multiple sclerosis: up-to-date.
Ancau M; Berthele A; Hemmer B
Expert Opin Biol Ther; 2019 Aug; 19(8):829-843. PubMed ID: 31027436
[TBL] [Abstract][Full Text] [Related]
15. Treating multiple sclerosis with monoclonal antibodies: a 2010 update.
Buttmann M
Expert Rev Neurother; 2010 May; 10(5):791-809. PubMed ID: 20420497
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Wingerchuk DM; Carter JL
Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
[TBL] [Abstract][Full Text] [Related]
17. Emerging monoclonal antibody therapies for multiple sclerosis.
Cree B
Neurologist; 2006 Jul; 12(4):171-8. PubMed ID: 16832236
[TBL] [Abstract][Full Text] [Related]
18. A safety review of current monoclonal antibodies used to treat multiple sclerosis.
Costa GD; Comi G
Expert Opin Drug Saf; 2023; 22(11):1011-1024. PubMed ID: 37314699
[TBL] [Abstract][Full Text] [Related]
19. Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
Deiß A; Brecht I; Haarmann A; Buttmann M
Expert Rev Neurother; 2013 Mar; 13(3):313-35. PubMed ID: 23448220
[TBL] [Abstract][Full Text] [Related]
20. Getting specific: monoclonal antibodies in multiple sclerosis.
Lutterotti A; Martin R
Lancet Neurol; 2008 Jun; 7(6):538-47. PubMed ID: 18485317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
